Navigation Links
Genomic Health Announces Third Quarter 2011 Financial Results and Business Progress
Date:11/1/2011

ed 2011 net income guidance; the company's belief that it is on track to launch tests for DCIS and MMR by the end of 2011 and to initiate a clinical validation study of its prostate cancer test currently in development in 2011; the attributes and focus of the company's product pipeline, including the prospects for its next generation cancer diagnostic programs; and the ability of the company's tests to impact clinical practice. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: our ability to increase usage of our tests; the risk that we may not obtain or maintain sufficient levels of reimbursement for our existing tests and any future tests we may develop, both domestically and abroad; our success in retaining current contracts or levels of reimbursement coverage for our tests; the risks and uncertainties associated with the regulation of our tests by the FDA and other agencies abroad; our ability to compete against third parties; our ability to develop and commercialize new tests and the timing thereof; unanticipated costs or delays in research and development efforts; our ability to successfully commercialize our products outside of the U.S.; our ability to obtain capital when needed; our ability to leverage our existing  infrastructure and generate net income while continuing to invest in future growth drivers; our history of operating losses; fluctuations in levels of growth; the results of clinical studies; the applicability of clinical study results to actual outcomes; and the other risks set forth in the company's filings with the Securities and Exchange Commission, including the risks set forth in the company's Quarterly Report on Form 10-Q for the period ended June 30, 2011. These forward- lookin
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Personalized Medicine - The Genomic Revolution in Cardiac Care
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014 /PRNewswire/ -  Pivotal Therapeutics Inc. (OTCQX:PVTTF; ... company with a focus on Omega-3 therapies for ... the Board of Directors approved the granting of ... the close of business on Friday, September 12, ... common shares of the Company were granted in ...
(Date:9/15/2014)... 15, 2014 /PRNewswire-iReach/ -- "Spain Aesthetic Lasers and ... market data on the Spain Aesthetic Lasers and ... millions of US dollars, volume (in units) and ... Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) Devices ... Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power Assisted ...
(Date:9/15/2014)... /PRNewswire-iReach/ -- On September 8, 2014, Dr. ... a Citizen Petition to Dr. Margaret Hamburg ... another Black Box Warning to Levaquin, Cipro, and ... a Black Box Warning for the following psychiatric ... or acts, loss of consciousness, delirium, depressed level ...
Breaking Medicine Technology:Pivotal Therapeutics Grants Incentive Stock Options 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3
... Reportlinker.com announces that a new ... its catalogue: Epidemiology: ... risk factor for deep vein thrombosis ... http://www.reportlinker.com/p0536561/Epidemiology-Major-Abdominal-Surgery-–-A-key-risk-factor-for-deep-vein-thrombosis-and-pulmonary-embolism.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory ...
... 2011 Zimmer Holdings, Inc. (NYSE and SIX: ZMH), ... will be participating in the Goldman Sachs 32nd Annual ... Palos Verdes, California, on June 7, 2011, at 8:40 ... of the presentation can be accessed via Zimmer,s Investor ...
Cached Medicine Technology:Reportlinker Adds Epidemiology: Major Abdominal Surgery - A key risk factor for deep vein thrombosis and pulmonary embolism 2Zimmer Holdings to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference 2
(Date:9/15/2014)... Sept. 15, 2014 (HealthDay News) -- U.S. heart experts ... electrocardiogram (ECG) when evaluating young people for underlying heart ... The American Heart Association and the American College of ... detailed personal and family medical history along with a ... or congenital (existing from birth) risks for sudden cardiac ...
(Date:9/15/2014)... September 12, 2014 - An estimated 8% of ... at some point during their lifetime. Brought on by ... the result of altered chemistry and physiology of the ... brain versus one altered by PTSD is essential to ... Center for BrainHealth at The University of Texas at ...
(Date:9/15/2014)... September 15, 2014 This year, ... founding in 2007. To mark the special occasion, Avenidas ... supporting the village and helping it to get started ... secure and fun community for seniors. Members of Avenidas ... and live in their own homes. They are able ...
(Date:9/15/2014)... Amy Norton HealthDay Reporter ... small number of medications are responsible for sending thousands of ... government study finds. Each year between 2007 and 2011, ... after getting a hold of family members, medication, according to ... "Three-quarters of those children were just 1 or 2 years ...
(Date:9/15/2014)... 15, 2014 Array Health ... technology, today announced that Independence Blue Cross ... southeastern Pennsylvania, has selected the Array Spectrum™ Private ... exchange marketplace for employers with more than 100 ... Spectrum™, Independence will offer employer groups a comprehensive ...
Breaking Medicine News(10 mins):Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:EEG study findings reveal how fear is processed in the brain 2Health News:Avenidas Village Celebrates Anniversary 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 3Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 2Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 3
... comes to chronic disease care, study finds , , TUESDAY, ... factor driving soaring rates of chronic disease in the ... their European counterparts, a new study finds. , It,s ... such as diabetes and heart disease account for some ...
... October 1, 2007 -- According to a study conducted ... lesbian, gay, and bisexual populations, blacks and Latinos do ... on the theory that stress related to prejudice would ... black lesbians, gay men, and bisexuals face prejudice related ...
... treatments can be the worst news a cancer patient ... of Missouri-Columbia is working steadfastly to learn why some ... drug cisplatin, in hopes of identifying the particular genes ... as possible. , In a paper published in the ...
... The first significant genetic finding in premenstrual dysphoric ... a very severe form of the more commonly known ... 5-8% of women, and is associated with severe emotional ... anger, headaches, weight gain and more, to such an ...
... When an adult suffers a cardiorespiratory arrest the rapid ... avoid sudden death in many cases. Nevertheless, defibrillation also ... that passes from the moment of the attack, the ... in order to avoid avoidable deaths, more and more ...
... N.J., Oct. 2 MedQuist Inc.,(Pink Sheets: ... multi-year agreement,with MedAssets Supply Chain Systems, one ... the relationship with MedAssets and,allowing them to ... speech,recognition and clinical documentation solutions. As ...
Cached Medicine News:Health News:Obesity Driving Rising U.S. Health Costs 2Health News:Obesity Driving Rising U.S. Health Costs 3Health News:Black gay men, lesbians, have fewer mental disorders than whites, says Mailman School of PH study 2Health News:MU researchers studying model to learn why certain cancers become resistant to drugs 2Health News:First significant genetic finding in severe PMS, or PMDD 2Health News:Algorithms to reanimate the heart 2Health News:Algorithms to reanimate the heart 3Health News:MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions 2Health News:MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions 3
Acuvue Toric is an exceptionally comfortable soft contact lens made especially for people with astigmatism. The Acuvue Toric lens is designed to comfortably fit the unique shape of your eye....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
Easyloupes are exceptional optics that you have come to expect from Oculus. Available in either 1.8x or 2.5x magnification and 40 cm working distance (15.75 inches), they have the well-known durabili...
... designed for computer operators who require ... placed at different heights and distanced ... Card is printed two sided- black ... and uses two type sizes to ...
Medicine Products: